Botulinum Toxin Market Value to Hit $8.5 Billion by 2025: Global Market Insights, Inc.

China botulinum toxin market share is set to achieve more than 11% CAGR from 2019 to 2025 owing to growing trends among the millennials about various aesthetic procedures.

Botulinum Toxin Market Forecasts 2019-2025

U.S. botulinum toxin market held majority share of 95% in 2018. Rising prevalence of medical conditions such as chronic migraine, cervical dystonia, muscle spasticity etc. will boost market growth. Moreover, presence of major industry players coupled with rising product demand among the millennials as well as middle-aged population will significantly drive the U.S. market.

Dermatology clinics for botulinum toxin procedures generated maximum revenue of USD 2.2 billion in the year 2018. Presence of state-of-the-art facilities in such settings encourage people to prefer dermatology clinics over other end-use settings. Moreover, increasing number of such clinics in developed regions will further augment segment growth.

Request for a sample of this research report @

Female segment of botulinum toxin market is expected to dominate the market, accounting for a total value of USD 4.4 billion in 2018. Ageing signs such as frown lines, forehead lines, crow's feet etc., can be reduced with botulinum toxin procedures, thus propelling segment growth. Moreover, increasing trends in middle-aged women to stay young and beautiful will further augment market growth.

Global Botulinum Toxin Market is projected to surpass USD 8.5 billion by 2025; according to a new research study published by Global Market Insights, Inc. Rising number of manufacturers in various economies will augment market growth. Moreover, increasing FDA approvals for various botulinum toxin products will further propel market growth. For instance, in 2016, Ipsen S.A. announced that it received U.S. FDA approval for its product, Dysport, that is intended for treatment of lower limb spasticity in children. Hence, growing number of manufacturers in various developed and developing economies coupled with increasing FDA approvals will drive the market growth.

Botulinum toxin is predominantly used in the treatment of various aging signs such as frown lines, forehead lines, square jaws, crow's feet and others. Moreover, increasing prevalence of cervical dystonia and acute migraine as well as growing cases of muscle spasticity is expected to boost product demand, thus augmenting botulinum toxin industry growth.

Browse key industry insights spread across 160 pages with 284 market data tables & 10 figures & charts from the report, “Botulinum Toxin Market Size By Product (Botulinum Toxin A, Botulinum Toxin B), By Application (Medical, Aesthetic), By Gender (Female, Male), By Age Group (13-19, 20-29, 30-39, 40-54, 55 and Above), By End-use (Hospitals, Dermatology Clinics, Spas & Cosmetic Centers), Industry Analysis Report, Regional Outlook (U.S., Canada, Germany, UK, France, Spain, Italy, Turkey, China, Japan, India, Australia, South Korea, Brazil, Mexico, Argentina, Egypt, Iran), Application Potential, Price Trends, Competitive Market Share & Forecast, 2019 – 2025” in detail along with the table of contents:

However, high cost associated with aesthetic procedures and poor reimbursement coverage for such procedures are few major growth hindering factors. Moreover, side effects such as allergic reactions, rash, nausea and muscle pain will limit the adoption rate of botulinum toxin in both aesthetic and therapeutic applications, thus restricting botulinum toxin market growth.

Botulinum toxin B is expected to witness considerable growth of 9.3% CAGR during the forecast timeframe. High growth is attributed to growing incidence of spasticity among geriatric population coupled with rising number of FDA approvals of novel botulinum toxin products for different applications. Growing application of botulinum toxin B in neurological disorders will boost botulinum toxin market growth in the future.

Aesthetic applications of botulinum toxin are expected to witness robust growth at 8.4% across the forecast timeframe. Botulinum toxin is predominantly used as a treatment to reduce appearance of fine lines and facial wrinkles. Growing influence of social media about frequently changing beauty trends will boost product demand, thereby propelling market growth.

People between the age group of 40-54 years generated maximum revenue of about USD 2.6 billion in 2018. Botulinum toxin procedures are growing at a robust rate among the middle-aged population. Factors such as increasing awareness about various aesthetic procedures, rising signs of ageing and growing disposable income are major factors augmenting segment growth.

Some of the key industry players operating in the global botulinum toxin market are Allergan, Eisai Co., Ltd., Galderma S.A., Hugel, Inc., Hugh source international ltd., Ipsen, Medytox, Inc., Merz Pharma and Revance Therapeutics, Inc. The industry participants emphasize on acquisitions and mergers, geographical expansion and novel product developments to strengthen their position in the market and gain competitive advantage over its peers. 

Make an inquiry for purchasing this report @

Browse Related Reports:

Dermatology Devices Market By Application (Skin Cancer, Skin Rejuvenation, Hair Removal, Body Contouring and Skin Tightening, Psoriasis), By Product (Diagnostic Devices {Imaging Devices, Dermatoscopes, Biopsy Devices}, Treatment Devices {Light Therapy Devices (LED Therapy), Lasers, Microdermabrasion Devices, Cryotherapy Devices, Electrosurgical Equipment, Liposuction Devices}), Industry Analysis Report, Regional Outlook (U.S., Canada, Germany, UK, France, Spain, Italy, China, India, Japan, Australia, Brazil, Mexico, Saudi Arabia, South Africa, UAE), Application Potential, Competitive Market Share & Forecast, 2018 – 2024

Dermal Filler Market By Type (Biodegradable {Temporary Biodegradable, Semi-Permanent Biodegradable}, Non-Biodegradable), By Material Type ( Hyaluronic Acid (HA), Calcium Hydroxylapatite (CaHA), Poly-L-lactic Acid, Polymethyl-Methacrylate Microspheres (PMMA), Fat), By Application (Facial Line Correction, Face Lift, Lip Enhancement), By End-Use (Dermatology Clinics, Hospitals), Industry Analysis Report, Regional Outlook (U.S., Canada, Germany, UK, France, Spain, Italy, Russia, China, Japan, India, Australia, South Korea, Brazil, Mexico, Argentina, South Africa, Saudi Arabia, UAE), Application Potential, Price Trends, Competitive Market Share & Forecast, 2018 – 2024

About Global Market Insights

Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider; offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy and biotechnology.

Contact Us:

Arun Hegde
Corporate Sales, USA
Global Market Insights, Inc.
Phone: 1-302-846-7766
Toll Free: 1-888-689-0688
Connect with us: Facebook | LinkedIn | Twitter

Source: Global Market Insights, Inc.


Categories: Dermatology/Skin Diseases

Tags: Botulinum Toxin A, Botulinum Toxin B, Botulinum Toxin Market, Dermatology Clinics

About Global Market Insights, Inc.

View Website

Global Market Insights Inc. is a global market research and management consulting company catering to leading corporations, non-profit organizations, universities and government institutions.

Arun Hegde
Arun Hegde
Corporate Sales, USA, Global Market Insights, Inc.
Global Market Insights, Inc.
4 North Main Street
Selbyville, DE 19975
United States